What is the prevalence of Prolactinoma?

TL;DR: Prolactinoma is the most common type of pituitary tumor, with an estimated prevalence ranging from 30 to 50 per 100,000 individuals in the general population. While often classified as a rare disease due to its localized nature, its high frequency among endocrine tumors means many cases remain undiagnosed or misidentified as other hormonal conditions.

Is Prolactinoma considered a rare disease?

While Prolactinoma is technically classified as a rare disease by many health organizations due to its prevalence falling below the 1 in 2,000 threshold in some regions, it is the most common secretory pituitary tumor. Clinical data suggests that many cases of Prolactinoma go undetected because small microadenomas often remain asymptomatic or cause only subtle hormonal imbalances. Consequently, the true prevalence of Prolactinoma is likely higher than current clinical reporting suggests.

How does Prolactinoma affect different demographics?

The distribution of Prolactinoma varies significantly by gender and age:

• Gender Distribution: In women of reproductive age, Prolactinoma is significantly more common, occurring 10 to 20 times more frequently than in men. However, in men, the tumors are often larger (macroadenomas) at the time of diagnosis.


• Age of Onset: Prolactinoma typically presents in adults aged 20 to 50. Pediatric cases are rare and often require genetic screening for conditions like Multiple Endocrine Neoplasia type 1 (MEN1).


• Geographic/Ethnic Variation: There is currently no definitive evidence of significant ethnic or geographic clustering for Prolactinoma, suggesting it is a global phenomenon.

Why is accurate prevalence data for Prolactinoma challenging?

Determining the exact number of people living with Prolactinoma is difficult due to the high incidence of incidentalomas—small tumors found during imaging for unrelated issues. Because many patients live with asymptomatic microadenomas, they are never entered into clinical registries. At DiseaseMaps.org, we have 58 community members currently sharing their experiences with Prolactinoma, providing a vital real-world perspective that complements the clinical data gathered from hospital-based studies.

Next steps

• Consult an endocrinologist to interpret blood prolactin levels and MRI imaging results.


• Join our community of 58 members at DiseaseMaps.org to share experiences and coping strategies.


• Discuss the necessity of genetic counseling if you have a family history of pituitary or endocrine tumors.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Prolactinoma.


• Orphanet: Pituitary prolactinoma (ORPHA:263435).


• The Pituitary Foundation: Understanding Prolactinomas.


• Endocrine Society: Clinical Practice Guidelines for Prolactinomas.